Akers Biosciences Inc Total Assets 2012-2020 | AKER

Akers Biosciences Inc total assets from 2012 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
Akers Biosciences Inc Annual Total Assets
(Millions of US $)
2019 $11
2018 $8
2017 $9
2016 $5
2015 $8
2014 $17
2013 $6
2012 $5
2011 $6
Akers Biosciences Inc Quarterly Total Assets
(Millions of US $)
2020-06-30 $19
2020-03-31 $9
2019-12-31 $11
2019-09-30 $5
2019-06-30 $6
2019-03-31 $7
2018-12-31 $8
2018-09-30 $10
2018-06-30 $13
2018-03-31 $13
2017-12-31 $9
2017-09-30 $5
2017-06-30 $7
2017-03-31 $7
2016-12-31 $5
2016-09-30 $6
2016-06-30 $6
2016-03-31 $7
2015-12-31 $8
2015-09-30 $11
2015-06-30 $13
2015-03-31 $15
2014-12-31 $17
2014-09-30 $17
2014-06-30 $18
2014-03-31 $18
2013-12-31 $6
2013-09-30 $0
2013-06-30 $0
2013-03-31 $0
2012-12-31 $5
2011-12-31 $6
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.018B $0.002B
Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company's products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $192.244B 34.47
Medtronic (MDT) Ireland $141.425B 26.64
Stryker (SYK) United States $80.011B 31.03
Boston Scientific (BSX) United States $51.576B 29.79
Lonza Group Ag (LZAGY) Switzerland $47.317B 0.00
Baxter (BAX) United States $40.812B 0.00
Terumo (TRUMY) Japan $28.725B 36.72
EssilorLuxottica Societe Anonyme (ESLOY) France $28.706B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.697B 23.81
ResMed (RMD) United States $26.786B 38.83
Sunny Optical Technology (SNPTF) China $17.923B 0.00
Bio-Rad Laboratories (BIO) United States $17.497B 79.13
Smith & Nephew SNATS (SNN) United Kingdom $16.300B 0.00
Insulet (PODD) United States $16.153B 683.44
DiaSorin S.p.A (DSRLF) Italy $12.616B 0.00
Quidel (QDEL) United States $11.478B 60.80
Shandong Weigao Medical Polymer (SHWGF) China $11.080B 0.00
GN STORE NORD (GNNDY) Denmark $9.996B 50.95
William Demant Holdings (WILYY) Denmark $8.193B 0.00
Canopy Growth (CGC) Canada $6.938B 0.00
Hill-Rom Holdings (HRC) United States $6.285B 15.60
Perrigo (PRGO) Ireland $6.009B 10.31
Haemonetics (HAE) United States $5.426B 36.16
Envista Holdings (NVST) United States $4.152B 28.32
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.001B 0.00
ICU Medical (ICUI) United States $3.975B 30.33
Abcam (ABCZY) $3.974B 0.00
Neogen (NEOG) United States $3.775B 61.90
National Vision Holdings (EYE) United States $3.391B 527.13
TG Therapeutics (TGTX) United States $3.313B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $2.818B 0.00
Agios Pharmaceuticals (AGIO) United States $2.695B 0.00
NuVasive (NUVA) United States $2.543B 35.44
DFB Healthcare Acquisitions (AHCO) United States $2.189B 0.00
AtriCure (ATRC) United States $1.693B 0.00
Owens & Minor (OMI) United States $1.626B 36.43
Cardiovascular Systems (CSII) United States $1.534B 0.00
NanoString Technologies (NSTG) United States $1.403B 0.00
Aphria (APHA) Canada $1.351B 0.00
InMode (INMD) Israel $1.245B 31.40
MacroGenics (MGNX) United States $1.153B 0.00
Quanterix (QTRX) United States $1.124B 0.00
OraSure Technologies (OSUR) United States $1.117B 0.00
Cerus (CERS) United States $0.990B 0.00
BioLife Solutions (BLFS) United States $0.968B 504.00
PetIQ (PETQ) United States $0.843B 24.18
Meridian Bioscience (VIVO) United States $0.817B 18.88
Lantheus Holdings (LNTH) United States $0.800B 11.08
Vapotherm (VAPO) United States $0.772B 0.00
Phibro Animal Health (PAHC) United States $0.726B 16.62
LeMaitre Vascular (LMAT) United States $0.672B 41.00
Eagle Pharmaceuticals (EGRX) United States $0.627B 88.64
Omeros (OMER) United States $0.575B 0.00
Surmodics (SRDX) United States $0.529B 58.03
Varex Imaging (VREX) United States $0.526B 22.80
Zynex (ZYXI) United States $0.496B 46.06
Aurora Cannabis (ACB) Canada $0.462B 0.00
Cytosorbents (CTSO) United States $0.364B 0.00
Surface Oncology (SURF) United States $0.363B 0.00
HEXO (HEXO) $0.342B 0.00
Viemed Healthcare (VMD) United States $0.341B 12.11
Utah Medical Products (UTMD) United States $0.306B 27.91
InfuSystems Holdings (INFU) United States $0.268B 51.12
SEMPERIT AG HLD (SEIGY) Austria $0.257B 0.00
Organigram Holdings (OGI) Canada $0.237B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.237B 0.00
Bovie Medical (APYX) United States $0.203B 0.00
Wound Management Technologies (SMTI) United States $0.191B 0.00
Exagen (XGN) United States $0.186B 0.00
Female Health (VERU) United States $0.171B 0.00
Chimerix (CMRX) United States $0.170B 0.00
Fonar (FONR) United States $0.130B 17.18
Liberty Health Sciences (LHSIF) United States $0.116B 0.00
Evolus (EOLS) United States $0.110B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Capricor Therapeutics (CAPR) United States $0.087B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.075B 0.00
Trinity Biotech (TRIB) Ireland $0.067B 12.73
United-Guardian (UG) United States $0.067B 15.03
Brainsway (BWAY) Israel $0.063B 0.00
Rockwell Medical (RMTI) United States $0.062B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.059B 0.00
Nephros (NEPH) United States $0.059B 0.00
MTech Acquisition (KERN) United States $0.043B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
FSD PHARMA INC (HUGE) Canada $0.023B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.022B 0.00
NF Energy Saving (BIMI) China $0.020B 0.00
Myomo (MYO) United States $0.016B 0.00
GUARDION HEALTH (GHSI) United States $0.016B 0.00
NeuroMetrix (NURO) United States $0.006B 0.00
Senestech (SNES) United States $0.005B 0.00